<DOC>
	<DOCNO>NCT02311478</DOCNO>
	<brief_summary>This study aim use validated tool well new technology examine change bleed pattern among woman initiate copper T380A IUD .</brief_summary>
	<brief_title>Tracking IUD Bleeding Experiences : An Evaluation Bleeding Profiles New Intrauterine Device Users</brief_title>
	<detailed_description>New user intrauterine device ( IUD ) likely discontinue use within first six month insertion . The common reason discontinuation copper IUD symptom related bleeding . Research look disturbance bleed pattern among new IUD user sparse date . Perceived change vaginal bleeding may impact method satisfaction , acceptability , continuation . There need update research evaluate change bleed pattern order provider well counsel patient expect month initiation IUD . A variety method evaluate bleed profile available . The World Health Organization ( WHO ) publish recommendation method collection analysis bleeding pattern . The WHO method include data collection bleeding day ( day blood loss require use menstrual pad tampon ) spotting day ( protection need ) use 90-day referent period . A second tool , pictorial blood loss assessment chart ( PBAC ) show inexpensive objective method assess blood loss . The PBAC take consideration heavy blood flow well number sanitary napkin tampon use . Additionally , new technology ( include mobile period track application ) make retrospective collection bleed data feasible prospective data collection accurate . This study aim incorporate validated tool well new technology examine change bleed pattern among woman initiate copper T380A IUD .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Copper</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy woman age 1840 year regular , normal menses ( last 37 day ) initiate IUD Women provide bleed information 3 cycle hormonal contraception ( nonhormonal IUD ) willing track bleed 180 day Women 6 12 month postpartum ( normal menses last 3 cycle ) Use hormonal contraceptive method previous 3 month Irregular duration menstrual cycle last 3 cycle ( &lt; 21 &gt; 35 day ) Recent history menstrual bleeding last less 3 day great 7 day base self report last 3 cycle Contraindication use ParaGardÂ® T380A IUD Mucopurulent cervicitis time IUD insertion Unable speak , read , write English Currently pregnant Plans desire pregnancy next 6 month Currently breastfeed Women &lt; 6 month postpartum Participation clinical investigation utilizing investigational drug medical device require invasive gynecologic procedure within 30 day prior enrollment Wilson 's disease Known coagulopathy bleed disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>